How cervical cancer is misdiagnosed or diagnosed late in Ireland

Cervical cancer is usually missed or diagnosed late in one of two ways, and the two are proven differently. The first is a screening error, where a smear taken under CervicalCheck is reported as clear when it was not, or an abnormal result is not acted on. The second is a symptomatic-pathway failure. Here a woman reports symptoms such as bleeding between periods, bleeding after sex, or persistent discharge, and these are dismissed without examination or referral.

The distinction matters because the breach question is different in each. A screening-error claim asks whether the screener met the standard a competent screener must apply. A symptomatic claim asks whether a GP or hospital doctor acted as a reasonably competent practitioner would when faced with red-flag symptoms. Three symptoms in particular should prompt examination and, where appropriate, referral: bleeding after sex, bleeding between periods, and persistent unexplained vaginal discharge or bleeding. One issue we see often is a recent clear smear being treated as a reason not to investigate these signs. Screening is not a diagnostic test, so a normal smear does not rule out cancer in a woman who later develops warning symptoms. Identifying which type of claim you have shapes the whole case, including which records matter and which experts are needed.

Most cervical cancer in Ireland develops slowly from changes caused by persistent high-risk human papillomavirus, often over the course of a decade or more before it becomes invasive. That slow progression is why a delay can be so significant in law. Cell changes that were treatable when they should have been found can become an invasive cancer requiring far more extensive treatment by the time the error is corrected Irish Cancer Society (Updated 2026) [1]. The legal harm flows from that lost window, a point we return to under loss of chance.

The CervicalCheck pathway and where it can fail

CervicalCheck is Ireland's national cervical screening programme, offering free screening to women and people with a cervix aged 25 to 65. A sample is taken and tested first for high-risk HPV. If that is found, the same sample is then checked for cell changes. Where abnormal changes are present, the person is referred to one of the colposcopy clinics around the country for closer examination and, if needed, a biopsy HIQA (Updated 2026) [2]. A claim can arise at any negligent link in that chain.

The pathway can fail at several points, any of which can found a claim where it falls below the expected standard and causes harm:

• a smear is misread as clear
• an inadequate sample is not flagged for a repeat
• a referral to colposcopy is not made, or is delayed
• a colposcopy or biopsy is misreported
• an abnormal result is never communicated to the woman or her GP

If your concern is how the programme itself handled results and audits, rather than your individual diagnosis, our cervical screening negligence claims page deals with the programme-level issues in detail.

Why the date of your test matters

The standard your screening is judged against changed in 2020, and few competitors reflect this. CervicalCheck used cytology, the traditional smear test, from 2008, then switched to primary HPV testing on 30 March 2020 HSE National Screening Service (Updated 2025) [3]. Under the older method, a screener examined the cells directly. Under the current method, the sample is tested for high-risk HPV first, and cells are only examined if HPV is found.

This shapes the expert evidence in a claim. A test before March 2020 is judged on how the cytology slide was read. A test after that date may turn instead on how an HPV-positive result was managed, or on a delay in follow-up or colposcopy referral. Establishing which standard applies is one of the first steps we take.

The Morrissey standard: what a screener must get right

Under Morrissey v HSE, a cervical screener must not report a smear as clear unless they have no doubt that the sample is adequate and free of suspicious material. This is the single most important principle in an Irish cervical screening claim, and it is where competitors stop at naming the case rather than explaining it.

In Morrissey & anor v Health Service Executive & ors [2020] IESC 6, a five-judge Supreme Court confirmed that the test for negligence remains the Dunne principles. A screener breaches that standard if they give a clear result while any doubt remains about the slide BAILII (Updated 2020) [4]. You can read our dedicated note on Morrissey v HSE for the full judgment analysis.

Standard of approach versus standard of care

The judgment drew a careful distinction that decides many cases. The standard of approach is a factual question: what a competent screener actually does. The standard of care is the legal duty the court applies. The court held that it is the evidence of the profession, not the judge, that sets where the line falls. Expert evidence on what a competent screener would have seen is therefore central to a claim.

The HSE's non-delegable duty

The Supreme Court also held that the HSE owes a non-delegable duty to women who use CervicalCheck. It is primarily liable for negligent laboratory screening even though it was found not to be vicariously liable, and even though the laboratories were independent contractors The Irish Times (Updated 2020) [5]. In practice this means a woman does not have to untangle which contractor was at fault. The HSE carries primary responsibility for the screening part of the programme.

One further point from Morrissey protects patients without imposing perfection. The court was clear that it does not require absolute certainty and that an error visible only with hindsight is not automatically negligence. The question is always whether a competent screener, applying ordinary care, could have given a clear result on that slide.

A separate wrong: not being told about the audit

The case also recognised the failure to tell a woman about a later audit of her own slides as a distinct wrong. Alongside the main award, the court made a nominal award of €10,000 for the HSE's failure to disclose the audit result to Ms Morrissey ⁴. That marked the non-disclosure as wrongful in its own right. Where you were never told that your slides had been re-examined, that non-disclosure can form part of a claim, separate from the original screening error.

Proving negligence: breach of duty and causation

A cervical cancer misdiagnosis claim has two parts, and both must be proven. The first is breach of duty: that the screener, GP, or hospital fell below the standard a reasonably competent professional would meet. The second is causation: that the breach actually caused or materially worsened your outcome.

Breach is measured by the Dunne principles from Dunne v National Maternity Hospital [1989] IR 91, the test the Supreme Court reaffirmed in Morrissey ⁴. Proving it usually needs independent expert evidence, and our page on breach of duty explains how that works.

The causation hurdle and the detectability problem

Causation is where many delay claims are won or lost. A claim has to show not only that there was a delay, but that an earlier, non-negligent diagnosis would have made a real difference to your treatment or outcome. In Crumlish v HSE [2024] IECA 244, the Court of Appeal dismissed a delayed breast cancer claim at the first causation hurdle. The plaintiff could not prove the cancer was actually detectable at the earlier point in time Courts Service of Ireland (Updated 2024) [6].

The same principle applies to cervical cancer. The case has to sit in a detectability window. The cancer or pre-cancer must have been identifiable when the alleged negligence happened, yet not already so advanced that an earlier diagnosis would have changed nothing. In cervical cases this often turns on whether treatable pre-cancerous change, known as CIN, was present and missed at the time of the smear. Bridging that gap calls for careful expert evidence, and our page on proving causation sets out the approach.

The staging shift that proves the harm

Cervical cancer is staged from one to four under the FIGO system, and the stage decides the treatment and the outlook. The legal injury in a delay claim is usually the staging shift. This is the difference between the stage at which the cancer should have been caught and the stage at which it was actually diagnosed. A shift from an early stage treatable by surgery to a later stage needing chemoradiation, often with a loss of fertility, is a concrete, provable harm. An expert is asked to measure that gap, because it is the gap, not the cancer itself, that the negligence caused.

Loss of chance: did the delay reduce your options?

Loss of chance asks whether a delay took away a real opportunity for cure or for less invasive treatment. It can apply even where it cannot be proven that you would have survived in any event. It matters in cervical cancer because survival may already have been uncertain, and the doctrine is not fully settled in Irish law.

Outcomes here are stage-dependent, which is why timing carries weight. The National Cancer Registry records that cervical cancer incidence in Ireland has been falling since 2010, by almost 7% a year, following the screening programme begun in 2008, with five-year relative survival around 61% National Cancer Registry Ireland (Updated 2024) [7]. When a delay allows a cancer to advance a stage before it is caught, that shift is what an expert is asked to weigh in valuing the lost chance.

In Philp v Ryan [2004] IESC 105 the Supreme Court awarded a total of €100,000, inclusive of an aggravated damages element, to a man whose prostate cancer diagnosis was delayed. He was compensated for the lost opportunity to consider treatment, even though he could not prove he would have lived longer Courts Service of Ireland (Updated 2004) [8]. A later decision, Quinn v Mid-Western Health Board [2005] IESC 19, took a stricter line. It required causation to be proven on the balance of probabilities, so the two authorities sit in tension.

Because the doctrine is unsettled, loss of chance is usually argued as an alternative route rather than a certainty. Irish law is more generous to patients here than the law in England and Wales. In Gregg v Scott, the House of Lords refused to award damages for a lost chance of recovery in a medical case. The Irish courts have not adopted that strict English position, which is one reason Irish-jurisdiction advice matters. Our page on loss of chance in cancer claims explains how it is run alongside ordinary causation.

Compensation: what a claim may include

Compensation in a cervical cancer misdiagnosis claim is made up of two parts: general damages for pain, suffering, and loss of amenity, and special damages for financial loss. General damages are assessed under the Personal Injuries Guidelines 2021. Clinical negligence claims do not go through the Injuries Resolution Board: they proceed directly through the courts, where special damages are not capped Judicial Council (Updated 2026) [9]. Every claim is different and any figure depends on the specific facts and medical evidence.

There is an outer limit on general damages. The Supreme Court in Morrissey confirmed a judicial cap of around €500,000 for the most severe cases. The Personal Injuries Guidelines 2021 now set the maximum at €550,000 for the most catastrophic injuries Judicial Council (Updated 2026) ¹⁰. A proposed increase to these figures was recommended in 2025 but has not become law. In a serious cervical cancer case the financial picture is often dominated by special damages, such as future care, loss of earnings, and treatment costs, rather than the general-damages figure.

The recoverable heads in a cervical claim fall into the two categories above. General damages cover the physical and psychological harm of delayed treatment and the effect of more extensive surgery, such as a radical hysterectomy and any resulting loss of fertility. Special damages cover the financial consequences: past and future loss of earnings, the cost of care, and medical and treatment costs. For how these are valued across cancer cases, see our cancer misdiagnosis compensation page, and where a diagnosis is terminal, our note on reduced life expectancy claims.

Time limits and date of knowledge

You generally have two years less one day to bring a cervical cancer misdiagnosis claim, but the clock does not always start on the day of the smear. It runs from your date of knowledge: the point at which you knew, or ought reasonably to have known, that you had a significant injury connected to the alleged negligence.

The two-year period was set by section 7 of the Civil Liability and Courts Act 2004, which reduced the previous three-year limit; the date-of-knowledge rule it runs from comes from the Statute of Limitations (Amendment) Act 1991. The date of knowledge can fall much later than the smear itself, for example when an audit or review later reveals that an earlier smear was wrong Irish Statute Book (Updated 1991) [10]. In Morrissey, the smears were taken in 2009 and 2012, and the audit was in 2014. The patient was not told until 2018, which shows how far apart those dates can be.

Because the date of knowledge is fact-sensitive and deadlines are strict, it is worth taking advice early even if you think time may have passed. There is also a separate early step: a formal letter of claim must be sent to the people you say were negligent, and the timeframe for this is short. Our pages on date of knowledge in cancer claims and the wider cancer misdiagnosis claims process explain how the limit and these pre-court steps are applied. Different rules apply for children and for fatal cases.

The stages of a claim and how long it takes

Most cervical cancer misdiagnosis claims take between two and four years from first instruction to resolution. The majority settle once the medical evidence is exchanged, rather than going to a full trial. The timeline depends on the complexity of the records, whether liability is disputed, and your own recovery and treatment. A claim moves through a recognised sequence of stages:

• First consultation, where we establish the facts and the likely date of knowledge
• Records and slides obtained under the Data Protection Act 2018
• Independent expert review by a cytopathologist and a gynaecological oncologist
• Letter of claim sent to the HSE, hospital, or practitioner responsible
• Exchange of medical evidence and negotiation, where most cases settle
• Court proceedings and, if needed, trial where a settlement is not reached

The early stages cannot be rushed, because a claim should not be issued until an independent expert confirms there are grounds. That groundwork is what protects you from bringing a claim that cannot succeed.

How we can help

If you are weighing up whether to take advice, a few questions help frame the conversation. None of them decides a claim, and answering yes to one does not mean you have a case. Tap each question to see what a solicitor would explore with you.

We act for women and families across Ireland in cervical cancer misdiagnosis claims, and we know how difficult it is to raise these questions while coping with illness or loss. Our role is to obtain and review your screening records and audit history. We request your CervicalCheck records and slides under your data-access rights in the Data Protection Act 2018, then have them assessed by independent experts. A cervical claim usually needs two: a cytopathologist to review the slides and a gynaecological oncologist to address treatment and outcome. We identify whether the failure was a screening error or a symptomatic-pathway failure, and instruct those experts. We then advise honestly on whether a claim can be brought and within what time.

References

1. Irish Cancer Society, Cervical cancer screening. cancer.ie (Updated 2026).
2. HIQA, CervicalCheck (The National Cervical Screening Programme). hiqa.ie (Updated 2026).
3. HSE National Screening Service, 5 years of HPV cervical screening in Ireland. healthservice.hse.ie (Updated 2025).
4. Morrissey & anor v Health Service Executive & ors [2020] IESC 6, Supreme Court (19 March 2020). BAILII (Updated 2020).
5. HSE and labs lose appeal over standard of care in cervical check cases. The Irish Times (Updated 2020).
6. Crumlish v HSE [2024] IECA 244, Court of Appeal. Courts Service of Ireland (Updated 2024).
7. National Cancer Registry Ireland, Cancer trends: cervical cancer. ncri.ie (Updated 2024).
8. Philp v Ryan [2004] IESC 105, Supreme Court. Courts Service of Ireland (Updated 2004).
9. Personal Injuries Guidelines. Judicial Council of Ireland (Updated 2026).
10. Statute of Limitations (Amendment) Act 1991. Irish Statute Book (Updated 1991).